Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 110 clinical trials
None
The Method ISET (Insulation by Size of Epithelial Tumor Cells)

The aim of this study is, i) to assess the presence and the frequency of CTC in NSCLC patients undergoing surgery by using cytopathological analysis after their isolation by size (ISET method), and, ii) to correlate the presence of CNHC with pTNM stage, histological subtype, and percentage of tumor cells …

carcinoma
  • 1 views
  • 07 Nov, 2020
  • 1 location
None
neoadjuvant_thymic Epithelial Tumor

This is a Phase II single center, open-label, single arm study in patients with unresectable thymic epithelial tumors (Masaoka stage III, IVA). Patients will be treated with Pembrolizumab 200 mg

  • 0 views
  • 01 Apr, 2021
  • 1 location
None
A Study of SI-B001 an EGFR/HER3 Bispecific Antibody in Locally Advanced or Metastatic Epithelial Tumors

In phase Ia study, the safety and tolerability of SI-B001 in patients with locally advanced or metastatic epithelial malignancies will be investigated to determine the dose-limiting toxicity

  • 1 views
  • 22 Jun, 2021
  • 1 location
None
The Effectiveness of High Resolution Microendoscopy for People Living With HIV

improved efficacy and resource utilization for cancer screening in people living with HIV for anal cancer and other epithelial cancers including the cervix, oral cavity, bladder, and GI tract.

  • 0 views
  • 18 Sep, 2021
  • 1 location
None
A Study of RC48-ADC for the Treatment of HER2-expressing Gynecological Malignancies

This study will evaluate the effectiveness and safety of intravenous injection of RC48-ADC in the treatment of HER2 expression (HER2 positive and HER2 low expression) gynecological malignancies.

  • 0 views
  • 16 Jan, 2022
  • 1 location
None
Chemoradiation With Enadenotucirev as a Radiosensitiser in Locally Advanced Rectal Cancer

The use of chemoradiotherapy (CRT), in combination with surgery is the standard of care in the treatment of locally advanced rectal cancer. However some patients don't respond well to radiation. More advanced radiotherapy techniques, that result in fewer toxicities, means that we are now able to combine new anti-cancer agents …

  • 5 views
  • 24 Jan, 2021
  • 1 location
None
Carboplatin and Paclitaxel With or Without Cediranib in Treating Women With Relapsed Ovarian Epithelial Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer

chemotherapy is more effective with or without cediranib in treating relapsed ovarian epithelial cancer, fallopian tube cancer, and primary peritoneal cancer. PURPOSE: This randomized phase III

ovarian epithelial cancer
carboplatin
fallopian tube
paclitaxel
tumor cells
  • 41 views
  • 07 Nov, 2020
  • 6 locations
None
Platino-resistance in Ovarian Cancer

Prospective, monocentric study aiming to identify factors involved in platinum based-chemotherapy resistance in patients with epithelial ovarian cancer (all stages). Patients will receive treatment (platinum based-chemotherapy) according to the standard practices. A prospective database and an associated biological collection will be performed during 5 years For each patient: clinical, biological, …

ascites
ovarian cancer
  • 0 views
  • 08 Aug, 2021
  • 1 location
None
A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression

This Phase 3 study is designed to compare the efficacy and safety of mirvetuximab soravtansine vs. investigator's choice chemotherapy in patients with platinum-resistant high-grade epithelial ovarian cancer, primary peritoneal, or fallopian tube cancer, whose tumors express a high-level of FRα. Patients will be, in the opinion of the Investigator, appropriate …

cancer of the ovary
doxorubicin
hormone therapy
neutrophil count
cancer
  • 88 views
  • 21 Jan, 2022
  • 175 locations
None
Long-acting G-CSF for Febrile Neutropenia

This study aims to analyze the effects of long-acting granulocyte colony stimulating factor (G-CSF) on the prevention febrile neutropenia (FN) in epithelial ovarian cancer. Patients are randomized into study group and control group. In study group, patients accept long-acting G-CSF 48 hours from the chemotherapy. While the control group accept …

granulocyte colony stimulating factor
cancer
neutropenia
epithelial ovarian cancer
colony stimulating factor
  • 10 views
  • 22 Jan, 2021